Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continue vs. Stop P2Y12 Inhibitor in Dental Procedures
NCT03103685Phase 4Unknown
- Sponsor
- Chiang Mai University
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clopidogrel, prasugrel, ticagrelor in coronary artery disease (CAD), sponsored by Chiang Mai University. Status: unknown.
02
Drugs
clopidogrelprasugrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03103685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103685.